Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 8Neoplasms 2Esophageal Neoplasms 2Stomach Neoplasms 1Platelet Glycoprotein IV Deficiency 1Pancreatic Intraductal Neoplasms 1Pancreatic Ductal Adenocarcinoma (PDAC) 1Pancreatic Cyst 1Leiomyoma 1Jaundice, Obstructive 1Gastrointestinal Stromal Tumors 1Fatty Liver 1Disease 1Cysts 1Colonic Neoplasms 1Carcinoma, Pancreatic Ductal 1Adenocarcinoma 1

Interventions

Gemcitabine 15130-nm albumin-bound paclitaxel 10Albumin-Bound Paclitaxel 7Oxaliplatin 5Paclitaxel 4Leucovorin 4Fluorouracil 4Carboplatin 4Cisplatin 3Cetuximab 3Bevacizumab 3pembrolizumab 2napabucasin 2Pemetrexed 2PEGPH20 2MK-4721 2Irinotecan 2tremelimumab 1selinexor 1relacorilant 1ponatinib 1neratinib 1irinotecan sucrosofate 1folfirinox 1ensituximab 1durvalumab 1contrast agent BR1 1cobimetinib 1ceritinib 1cc-486 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Pancreatic Ductal × Endosonography × Gastrointestinal × Clear all
NCT05621824 2024-04-09

A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUS

Peking Union Medical College Hospital

Not yet recruiting
900 enrolled
Gastrointestinal

Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡